News: Updates

Fragile X study offers hope of new autism treatment

The Azrieli Neurodevelopmental Research Program (ANRP), a partnership between the Azrieli Foundation and Brain Canada, supports advanced research on neurodevelopmental disorders, with a focus on Fragile X Syndrome. Research out of the McGill University lab of Dr. Nachum Sonenberg, supported by the ANRP was recently published in CellReports.

To find out more about how this groundbreaking study could open the door to uniquely targeted treatments for Fragile X Syndrome, read the McGill University news report.